Friday, November 9, 2012

http://t.co/No

Retweeted NEJM (@NEJM): Malaria vaccine trial should be used as opportunity to enlighten researchers regarding effective host response. http://t.co/NodB6jn9

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/No
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)